Momenta Pharmaceuticals, Inc. (Nasdaq: MNTA) 58.3% LOWER; said collaboration partner, Sandoz Inc., a division of Novartis, had received a letter ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE